Latest Opioid Stories
BuTab, an Enteric-Coated Buprenorphine Product Candidate, to be Compared with Marketed Intravenous and Sublingual Formulations NEW YORK, Feb.
NEW YORK, Feb. 17, 2015 /PRNewswire/ -- Lightlake Therapeutics Inc.
Comprehensive market research report “Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain” elaborated by MP
VALLEY COTTAGE, N.Y., Feb.
FREDERICK, Md., Feb.
WAYNE, Pa., Feb.
Transaction provides BDSI the opportunity to seek a new partner for ONSOLIS in the U.S., Canada and Mexico RALEIGH, N.C., Jan.
A Once-Daily Opioid Formulated with Abuse-Deterrent Properties STAMFORD, Conn., Jan. 26, 2015 /PRNewswire/ -- Purdue Pharma today announced the U.S.
-- Law Enforcement Officers in 13 States Now Carrying EVZIO -- RICHMOND, Va., Jan.
- A woman chauffeur.
- A woman who operates an automobile.